Trial intelligence / Profile preview

Dose-selection Study of MDCO-2010 in Cardiac Surgery

NCT01530399Phase 2Terminated

Sponsor
The Medicines Company
Start
Mar 2012
Primary completion
Nov 2012
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of MDCO-2010, sponsored by The Medicines Company. Started Mar 2012; status: terminated.

02

Drugs

MDCO-2010

Beyond the preview

Go deeper on NCT01530399.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01530399.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call